Bob Dagher
Chief Tech/Sci/R&D Officer presso BRAINSTORM CELL THERAPEUTICS INC.
Patrimonio netto: 142 945 $ in data 31/03/2024
Profilo
Dr. Bob Dagher, MD, is a Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Dr. Dagher was previously employed as a Chief Medical Officer by Enveric Biosciences, Inc., a Chief Medical Officer-WCG MedAvante-ProPhase by Cadent Therapeutics, Inc., a Senior Medical Director by Covance, Inc., and a Chief Medical Officer by MedAvante-ProPhase, Inc. He received his undergraduate degree from Université de Bordeaux and an undergraduate degree from Faculté De Médecine Necker Enfants Malades Université.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2024 | 253 000 ( 0.52% ) | 142 945 $ | 31/03/2024 |
Posizioni attive di Bob Dagher
| Società | Posizione | Inizio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 16/04/2024 |
Precedenti posizioni note di Bob Dagher
| Società | Posizione | Fine |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2021 |
| COVANCE INC. | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | - |
Formazione di Bob Dagher
| Université de Bordeaux | Undergraduate Degree |
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
| MedAvante-ProPhase, Inc. |
- Borsa valori
- Insiders
- Bob Dagher
